These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22399158)

  • 21. Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial.
    Park JH; Park MS; Lee SJ; Jeong WK; Lee JY; Park MJ; Han K; Nam CM; Park SH; Lee KH
    BMC Cancer; 2017 Apr; 17(1):279. PubMed ID: 28420329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of new tumors by intraoperative ultrasonography during repeated hepatic resections for hepatocellular carcinoma.
    Zhang K; Kokudo N; Hasegawa K; Arita J; Tang W; Aoki T; Imamura H; Sano K; Sugawara Y; Makuuchi M
    Arch Surg; 2007 Dec; 142(12):1170-5; discussion 1176. PubMed ID: 18086983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fate of metastatic foci after chemotherapy and usefulness of contrast-enhanced intraoperative ultrasonography to detect minute hepatic lesions.
    Uetake H; Tanaka S; Ishikawa T; Sugihara K; Arii S
    J Hepatobiliary Pancreat Sci; 2012 Sep; 19(5):509-14. PubMed ID: 22539087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agent.
    Numata K; Fukuda H; Ohto M; Itou R; Nozaki A; Kondou M; Morimoto M; Karasawa E; Tanaka K
    Eur J Radiol; 2010 Aug; 75(2):e67-75. PubMed ID: 20015603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular carcinoma: surveillance CT schedule after hepatectomy based on risk stratification.
    Liu D; Fong DY; Chan AC; Poon RT; Khong PL
    Radiology; 2015 Jan; 274(1):133-40. PubMed ID: 25162308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography.
    Maruyama H; Takahashi M; Ishibashi H; Okugawa H; Okabe S; Yoshikawa M; Yokosuka O
    Liver Int; 2009 May; 29(5):708-14. PubMed ID: 18803588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depiction of portal supply in early hepatocellular carcinoma and dysplastic nodule: value of pure arterial ultrasound imaging in hepatocellular carcinoma.
    Kudo M; Hatanaka K; Inoue T; Maekawa K
    Oncology; 2010 Jul; 78 Suppl 1():60-7. PubMed ID: 20616586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of irreversible electroporation ablation zone using Kupffer-phase contrast-enhanced ultrasound images with Sonazoid.
    Sugimoto K; Moriyasu F; Yoshiyuki K; Imai Y
    J Med Ultrason (2001); 2014 Oct; 41(4):531-2. PubMed ID: 27278039
    [No Abstract]   [Full Text] [Related]  

  • 29. Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
    Wang XY; Chen D; Zhang XS; Chen ZF; Hu AB
    J Dig Dis; 2013 Aug; 14(8):433-8. PubMed ID: 23615075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of intraoperative diagnosis of hepatic tumors located at the liver surface and hepatic segmental visualization using indocyanine green-photodynamic eye imaging.
    Abo T; Nanashima A; Tobinaga S; Hidaka S; Taura N; Takagi K; Arai J; Miyaaki H; Shibata H; Nagayasu T
    Eur J Surg Oncol; 2015 Feb; 41(2):257-64. PubMed ID: 25447030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast-enhanced sonography-guided radiofrequency ablation for the local recurrence of previously treated hepatocellular carcinoma undetected by B-mode sonography.
    Miyamoto N; Hiramatsu K; Tsuchiya K; Sato Y
    J Clin Ultrasound; 2010 Sep; 38(7):339-45. PubMed ID: 20572066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraoperative ultrasonography in patients who undergo liver resection or transplantation for hepatocellular carcinoma.
    Silberhumer GR; Steininger R; Laengle F; Muehlbacher F; Zacherl J; Pokieser P
    Surg Technol Int; 2004; 12():145-51. PubMed ID: 15455319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response evaluation of transcatheter arterial chemoembolization in hepatocellular carcinomas: the usefulness of sonazoid-enhanced harmonic sonography.
    Xia Y; Kudo M; Minami Y; Hatanaka K; Ueshima K; Chung H; Hagiwara S; Inoue T; Ishikawa E; Kitai S; Takahashi S; Tatsumi C; Ueda T; Hayaishi S; Maekawa K
    Oncology; 2008; 75 Suppl 1():99-105. PubMed ID: 19092278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI with Gd-EOB-DTPA to detect small hepatocellular carcinoma.
    Kunishi Y; Numata K; Morimoto M; Okada M; Kaneko T; Maeda S; Tanaka K
    AJR Am J Roentgenol; 2012 Jan; 198(1):106-14. PubMed ID: 22194485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience.
    Catalano O; Izzo F; Vallone P; Sandomenico F; Albino V; Nunziata A; Fusco R; Petrillo A
    Acta Radiol; 2015 Feb; 56(2):133-42. PubMed ID: 24523360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrast-enhanced ultrasonography with sonazoid. Comparison with superparamagnetic iron oxide magnetic resonance images.
    Inoue T; Kudo M; Hatanaka K; Takahashi S; Kitai S; Ueda T; Ishikawa E; Hagiwara S; Minami Y; Chung H; Ueshima K; Maekawa K
    Oncology; 2008; 75 Suppl 1():48-54. PubMed ID: 19092272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined use of contrast-enhanced intraoperative ultrasonography and a fluorescence navigation system for identifying hepatic metastases.
    Uchiyama K; Ueno M; Ozawa S; Kiriyama S; Shigekawa Y; Yamaue H
    World J Surg; 2010 Dec; 34(12):2953-9. PubMed ID: 20734045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
    Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
    Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined intraoperative use of contrast-enhanced ultrasonography imaging using a sonazoid and fluorescence navigation system with indocyanine green during anatomical hepatectomy.
    Uchiyama K; Ueno M; Ozawa S; Kiriyama S; Shigekawa Y; Hirono S; Kawai M; Tani M; Yamaue H
    Langenbecks Arch Surg; 2011 Oct; 396(7):1101-7. PubMed ID: 21918930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
    Takizawa K; Numata K; Morimoto M; Kondo M; Nozaki A; Moriya S; Ishii T; Oshima T; Fukuda H; Okada M; Takebayashi S; Maeda S; Tanaka K
    Eur J Radiol; 2013 Sep; 82(9):1471-80. PubMed ID: 23769188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.